ADCT ADC Therapeutics SA: institutional ownership and insider trading
119 funds reported holding $93.7M of ADC Therapeutics SA in their latest 13F filings; in Q2 2026 funds net sold $2.96M, with 26 new positions and 30 funds selling out; over the last 12 months insiders bought $0 and sold $19.6M on the open market.
Famous investors holding ADCT
- Izzy Englander (Millennium Management): $3.26M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.20M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $828K, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $770K, 0.0% of the portfolio
Largest institutional holders of ADCT
- Nantahala Capital Management, LLC — $13.2M
- Redmile Group, LLC — $12.3M
- TCG Crossover Management, LLC — $12.2M
- Prosight Management, LP — $8.37M
- BlackRock, Inc. (BLK) — $7.51M
- VANGUARD GROUP INC — $3.99M
- Point72 Asset Management, L.P. — $3.93M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $3.26M
- MILLENNIUM MANAGEMENT LLC — $3.26M
- Vantage Consulting Group Inc — $2.41M
Recent ADCT insider trades
- Apr 2, 2026: Redmile Group, LLC sold 5,880,415 shares ($19.6M)
- Dec 11, 2024: Redmile Group, LLC bought 200,000 shares ($609K)
- Dec 4, 2024: Redmile Group, LLC sold 25,352 shares ($52.5K)
5%+ owners
- Redmile Group, LLC: 9.9% (Schedule 13G/A, filed Apr 24, 2026)
- Nantahala Capital Management, LLC: 9.7% (Schedule 13G, filed Aug 14, 2026)
- BlackRock, Inc.: 5.4% (Schedule 13G, filed Jul 27, 2026)